UNITED STATES
SECURITIES AND EXCHANGE COMMISSION
WASHINGTON, DC 20549
Form 8-K
CURRENT REPORT
Pursuant to Section 13 or 15(d) of The Securities Exchange Act of 1934
Date of Report (Date of earliest event reported): January 6, 2005
---------------
Ibis Technology Corporation
---------------------------
(Exact name of registrant as specified in its charter)
Massachusetts 0-23150 04-2987600
(State or other jurisdiction (Commission (IRS Employer
of incorporation) File Number) Identification No.)
32 Cherry Hill Drive, Danvers, Massachusetts 01923
- -----------------------------------------------------
(Address of principal executive offices) (Zip Code)
Registrant's telephone number, including area code: (978) 777-4247
--------------
Check the appropriate box below if the Form 8-K filing is intended to
simultaneously satisfy the filing obligation of the registrant under any of the
following provisions (see General Instruction A.2. below):
[ ] Written communications pursuant Rule 425 under the Securities Act (17 CFR
230.425)
[ ] Soliciting material pursuant to Rule 14a-12 under the Exchange Act (17
CFR 240.14a-12)
[ ] Pre-commencement communications pursuant to Rule 14d-2(b) under the
Exchange Act (17 CFR 240.14d-2(b))
[ ] Pre-commencement communications pursuant to Rule 13e-4(c) under the
Exchange Act (17 CFR 240.13e-4(c))
ITEM 8.01. OTHER EVENTS
On January 6, 2005, Ibis Technology Corporation announced receipt of an order
for an Ibis i2000 oxygen implanter from a leading silicon wafer manufacturer. A
copy of the press release is being furnished as Exhibit 99.1 to this Current
Report on Form 8-K. This information shall not be deemed "filed" for purposes of
Section 18 of the Securities Exchange Act of 1934, as amended (the "Exchange
Act"), or incorporated by reference in any filing under the Securities Act of
1933, as amended, or the Exchange Act, except as shall be expressly set forth by
specific reference in such a filing.
ITEM 9.01. FINANCIAL STATEMENTS AND EXHIBITS.
(a) Not applicable.
(b) Not applicable.
(c) Exhibits
Exhibit 99.1. Press Release issued by Ibis Technology Corporation on
January 6, 2005.
SIGNATURES
Pursuant to the requirements of the Securities Exchange Act of 1934, the
registrant has duly caused this report to be signed on its behalf by the
undersigned hereunto duly authorized.
IBIS TECHNOLOGY CORPORATION
---------------------------
Date: January 6, 2005 /s/ William J. Schmidt
---------------------------
William J. Schmidt
Chief Financial Officer
EXHIBIT INDEX
-------------
Exhibit
Number Description
- ------ -----------
99.1 Press Release Announcing Receipt of an Order for an Ibis i2000 Oxygen
Implanter.